MedPath

Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum

Phase 1
Completed
Conditions
Molluscum Contagiosum
Interventions
Drug: Group A received cryotherpay
Drug: Group B received 10% Potassium Hydroxide Solution
Registration Number
NCT05897112
Lead Sponsor
Combined Military Hospital Abbottabad
Brief Summary

A total of sixty patients presented to the outpatient dermatology department of Combined military hospital (CMH) Abbottabad with signs of molluscum contagiosum clinically diagnosed meeting inclusion criteria were enrolled. Sample size was calculated using WHO sample size calculator. They were divided into two groups i.e Group A and Group B using lottery method. Patients in Group A were subjected to cryotherapy (liquid nitrogen gas) whereas patients in Group B patients were subjected to 10% potassium hydroxide solution for 3 weeks and were followed up at 2nd, 4th, 8th and 12th week for observing the progress of therapy in both groups on each follow up visit and ascertaining the efficacy respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • clinical diagnosis of molluscum contagiosum having 3-20 lesion
  • no history of treatment before
  • willingness to participate (given by parents)
Exclusion Criteria
  • Patients with facial lesions
  • known immunodeficiency
  • tendency for hypertrophic scarring
  • known hypersensitivity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group A received cryotherapyGroup A received cryotherpayGroup A were subjected to weekly cryotherapy with a cotton stick dip ped in Liquid Nitrogen for 02 Freezes and Thaw Cycle of 07 seconds with each cycle 10 seconds apart for 3 weeks
Group B received 10% Potassium Hydroxide SolutionGroup B received 10% Potassium Hydroxide SolutionGroup B applied 10% Potassium Hydroxide solution twice daily with the help of a cotton tip applicator until lesion showed signs of inflammation or clearance for 3 weeks
Primary Outcome Measures
NameTimeMethod
Efficacy was assessed at 12th week by the clearance of lesion or not12 weeks

Final evaluation in terms of efficacy was done at the follow up visit in 12th week and the method was termed as effective (Yes) on achieving complete clearance of lesions confirmed on clinical \& physical examination of the affected areas by a consultant dermatologist using dermoscopy showing complete resolution of lesions. However, if lesions were not completely cleared at the end of 12th week, the treatment method was labelled as ineffective (No).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CMH Abbottabad

🇵🇰

Abbottābād, Khyber Pakhtunkhwa, Pakistan

© Copyright 2025. All Rights Reserved by MedPath